Navigation Links
Chemo-free treatment a possibility for leukemia/lymphoma
Date:3/19/2014

e across another class of drugs in my career that has been so successful for leukaemia or lymphoma."

Current therapies, such as chemotherapy, intensive chemo-immunotherapy (chemotherapy combined with immunotherapy) or stem cell transplant are effective but due to the aggressive nature of these cancers, patients always relapse and eventually run out of options.

These drugs work by inhibiting Bruton's tyrosine kinase (BTK), a protein which plays a role in the signals that cause growth in cancerous cells. Blocking this causes the cancerous cells to die but normal cells are unaffected.

With an average survival rate of four to five years, the new developments in BTK inhibiting drugs could dramatically improve the life expectancy and quality of life for patients with terminal forms of leukaemia and lymphoma who have run out of other treatment options.

David Hodge, 74, from Plymouth, was the first in the world to be treated with this new medication and more than a year on from the start of the trial is feeling the benefits.

Prior to starting the trial in September 2012, David had only several months to live. This was due to his immune system not functioning and also following years of treatment he had become resistant to all other treatments.

Professor Rule continued: "To be brutal, David had no other option. He was resistant to other forms of treatments so I am just pleased to have been able to access this drug and offer it to him."

When asked whether this was the outcome he imagined the trial to have a year ago, Professor Rule said: "I have done a lot of drug trials in my career; this drug and its predecessor, which I was fortunate to be the first person in Europe to use - they are transformational as far as I am concerned.

"So, did I expect this to happen? No, but I was hopeful that this drug would be more effective than similar drugs we could trial.

"Normally what you expect with tri
'/>"/>

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Sepsis study comparing 3 treatment methods shows same survival rate
2. Dartmouth researchers develop new approach to chronic lymphocytic leukemia treatment
3. Gene variants protect against relapse after treatment for hepatitis C
4. PSA-testing and early treatment decreases risk of prostate cancer death
5. Emerging multi-drug resistant infections lack standard definition and treatment
6. Making treatment of rare blood disorder more affordable and effective
7. Discoveries point to more powerful cancer treatments, fewer side effects
8. A novel treatment may reduce myocardial infarction size
9. Cancer targeted treatments from space station discoveries
10. 3-D printer creates transformative device for heart treatment
11. Editorial illustrates shift away from glycemic control in diabetes treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... Analysis to 2023” focuses on the current treatment landscape, ... colorectal cancer market. TS-1 is an anti-cancer drug which ... administered orally and is also used for treating gastric ... gimestat and otastat potassium. The drug was first approved ...
(Date:12/25/2014)... CA (PRWEB) December 25, 2014 The short ... was created in honor of a true 9/11 hero, ... two film festivals including the 24 hours of Nuremberg International ... in Bangladesh. , Actress, screenwriter and director Luciana ... produce this film together with her husband, Gregory Graham ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping tips ... the models at LunaDress.co.uk come with big discounts, up to 80 ... can turn out to be a most exciting memory and can ... bring surprise to a wedding. On the updated fashion blog, ladies ... for a big day . , Going out with friends to ...
(Date:12/25/2014)... Thompson HealthDay Reporter WEDNESDAY, ... in on a "fountain of youth" drug that can delay ... adults, a new study suggests. Seniors received a significant ... targets a genetic signaling pathway linked to aging and immune ... The experimental medication, a version of the drug rapamycin, ...
(Date:12/25/2014)... 2014 Residents at Abernethy ... showed their generous spirit by providing holiday gifts ... Parenting Network- Grandparents Raising Grandchildren program. , Following ... the largest Christmas tree on the campus of ... residents of the Abernethy Village Association (AVA). Each ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Retirement Community Residents Make Impact During Holiday Season 2
... Inc. (NYSE: CRE ) ("Care" or the "Company") ... of $0.17 per share of common stock for the fourth quarter ... common shareholders of record on March 26, 2009. In addition, the ... Financial Officer and Treasurer effective March 17, 2009. Mr. Hughes ...
... More Now Available SAN FRANCISCO, March 16 Posit Science ... with information about how the brain functions and what people ... Brain Awareness Week, which begins today, the company is making ... how the brain operates and dispel myths about the brain. ...
... Is Justified by Revenue Increases that Show No Sign of ... draw smiles from President Obama, this month LTC Financial Partners ... care insurance agencies, will pay its shareholders $1,228,820 in dividends, ... can do it because business is great," says Cameron Truesdell, ...
... will be releasing both Raima Database Manager (RDM) ... as version 9.1 and RDM Server will be ... extend RDM,s high availability by providing replication between ... will provide developers of embedded systems with an ...
... Nepstar,Chain Drugstore Ltd. (NYSE: NPD ) ... in China based on the number of directly ... has declared a cash,dividend of US$0.35 per American ... to the sum of the Company,s undistributed net,income ...
... and more research is needed, study says , , SUNDAY, ... allergies to a carefully administered daily oral dose of ... some of them appear to have lost their allergies, ... Duke University Medical Center and Arkansas Children,s Hospital, cautioned ...
Cached Medicine News:Health News:Care Investment Trust Inc. Announces Quarterly Dividend - Appoints Paul F. Hughes CFO and Treasurer 2Health News:Care Investment Trust Inc. Announces Quarterly Dividend - Appoints Paul F. Hughes CFO and Treasurer 3Health News:Posit Science Provides Free Brain Health Tips and Tools in Celebration of Brain Awareness Week 2Health News:No Bailout Needed: Long Term Care Insurance Leader Declares Dividend, Plans Strong 2009 Growth 2Health News:Birdstep Technology Announces The Dual Upcoming Release Of Its Raima Database Manager Products 2Health News:Birdstep Technology Announces The Dual Upcoming Release Of Its Raima Database Manager Products 3Health News:China Nepstar Chain Drugstore Announces Dividend 2Health News:China Nepstar Chain Drugstore Announces Dividend 3Health News:Exposure to Peanuts May Build Tolerance to Allergy 2Health News:Exposure to Peanuts May Build Tolerance to Allergy 3
(Date:12/24/2014)... CHAPEL HILL, N.C. , Dec. 23, 2014 /PRNewswire/ ... marketplace success. As the key link between the medical ... will grow even more in the coming years as ... relationships. According to research by benchmarking ... and MSLs can gain an important edge is by ...
(Date:12/22/2014)... 22, 2014 Apnea Sciences ( www.apneasciences.com ) ... Aliso Viejo , California.  Jimmy ... tremendous growth and worldwide expansion, a new facility with ... the anti snore cure have exceeded our expectations and ... are now in 23 countries and will be increasing ...
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research ... announced the addition of the "Investment Analysis ... report to their offering. ... investments in the US medical device sector identifies ... equity and venture capital investments, and mergers and ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2Investment Analysis of the US Medical Device Sector 2
... 2012 This is your last week to ...   Hundreds of Suppliers ,   Educational ...     all in   One Convenient Location. ... pre-register for free at   http://www.MDMEast.com . ...
... -- Denton Vacuum LLC, a leading supplier of ... website that guides visitors to information tailored specifically ... mirror what it,s like to work with our company: ... technical drivers," says Rod Moore, Denton,s president. The new ...
Cached Medicine Technology:Medical Device Developers - Network at MD&M East Next Week 2Medical Device Developers - Network at MD&M East Next Week 3Denton Vacuum's New Website Organizes Thin-Film Technology Information By Industry 2
... designed for patient comfort as well as dependable ... at 5cm intervals and line marked each centimeter., ... available spanning most clinical needs and the range ... or two sensors., ,Flexilog single-use catheters are ...
... UES catheter is made of two probes ... choice of sensor distance., ,VersaFlex disposable ... ,Alpine's VersaFlex catheters are the smallest ... French), and are the perfect combination of ...
... Slimline single-use pH catheters are ... cross-contamination and allow greater patient comfort ... ,Medtronic pH measurement systems have been ... that allow an accurate room-temperature calibration. ...
FLEXILOG spare part....
Medicine Products: